InsiderTrades

Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD

Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001209191-23-016721 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-07 2023-03-04+ TEVA Stark David Matthew EVP CLO M - OptEx — +66.0K 68.9K +2,218% —
D 2023-03-07 2023-03-03 TEVA Stark David Matthew EVP CLO A - Grant $0.00 +94.6K 94.6K New $0
DM 2023-03-07 2023-03-04+ TEVA Stark David Matthew EVP CLO M - OptEx $0.00 -66.0K 40.4K -62% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2023-03-04 M A 13,931 — 16,905.39 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
2 Common Ordinary Shares 2023-03-04 M A 31,836 — 48,741.39 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
3 Common Ordinary Shares 2023-03-05 M A 20,199 — 68,940.39 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
4 Derivative Restricted Share Units 2023-03-03 A A 94,621 $0.00 94,621 D — · — to — 94,621 Ordinary Shares (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F3) Restricted share units were granted on March 3, 2023, with 23,655 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 23,656 vesting on March 3, 2027.
5 Derivative Restricted Share Units 2023-03-04 M D 13,931 $0.00 0 D — · — to — 13,931 Ordinary Shares (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F4) Restricted share units were granted on March 4, 2019, with 13,930 vested on each of March 4, 2021 and March 4, 2022, and 13,931 vested on March 4, 2023.
6 Derivative Restricted Share Units 2023-03-04 M D 31,836 $0.00 95,509 D — · — to — 31,836 Ordinary Shares (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F5) Restricted share units were granted on March 4, 2022, with 31,836 vested on March 4, 2023, 31,836 vesting on each of March 4, 2024 and March 4, 2025 and 31,837 vesting on March 4, 2026.
7 Derivative Restricted Share Units 2023-03-05 M D 20,199 $0.00 40,400 D — · — to — 20,199 Ordinary Shares (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F6) Restricted share units were granted on March 5, 2021, with 20,199 vested on each of March 5, 2022 and March 5, 2023, 20,199 vesting on March 5, 2024, and 20,201 vesting on March 5, 2025.